TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Akari Therapeutics PLC (ADR) (NASDAQ:AKTX) Investor Securities Class Action Lawsuit 05/12/2017

  • If you purchased shares of Akari Therapeutics PLC (ADR) (NASDAQ:AKTX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

November 28, 2018 - The court preliminarily approved the settlement. August 3, 2018 - A stipulation of settlement was filed by the parties. May 12, 2017 (Shareholders Foundation) - An investor in shares of Akari Therapeutics PLC (ADR) (NASDAQ:AKTX) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by A...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: